Clinical Trials

DermatologicLymphoidOther hematologic neoplasmThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Lymphoma, Follicular, Melanoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05487651 2023-05-18

ANCHOR2

LymphoidOther hematologic neoplasmSarcoma

36 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04356846 2023-05-01

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

74 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03510767 2023-04-14

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

60 enrolled

Lymphoma, Recurrence

NCT05495035 2023-03-02

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

22 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

29 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT05727683 2023-02-14

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

33 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04381741 2023-02-06

CICPD

24 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT04887025 2023-02-06

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

25 enrolled

Recurrence, Lymphoma, B-Cell

NCT05585996 2023-02-06

Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma

70 enrolled

Recurrence, Lymphoma, B-Cell

NCT05667155 2023-02-06

Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

48 enrolled

Lymphoma, B-Cell

NCT05691153 2023-01-19

ThisCART19A for B-NHL Relapsed After Auto-CAR T

20 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05679687 2023-01-11

ThisCART19A Bridging to alloHSCT for R/R B-ALL

20 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03775525 2022-12-23

GEN602

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

127 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

90 enrolled

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

NCT05596266 2022-10-27

CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia

20 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04118868 2022-10-12

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

10 enrolled

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT05569057 2022-10-07

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

100 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

71 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT04684472 2022-09-26

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

18 enrolled

Leukemia, Lymphoma, B-Cell

NCT05363800 2022-07-29

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

198 enrolled

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence

NCT05458180 2022-07-14

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

18 enrolled

Lymphoma, T-Cell, Peripheral

NCT05453669 2022-07-12

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

12 enrolled

Lymphoma, B-Cell

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

24 enrolled

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05275504 2022-06-09

Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

37 enrolled

B-Cell Malignancies

NCT05410041 2022-06-08

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

15 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05398614 2022-06-01

SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies

18 enrolled

Lymphoma, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05387226 2022-05-24

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

6 enrolled